| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
968 |
917 |
$73K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
264 |
250 |
$6K |
| 87400 |
|
450 |
218 |
$4K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
68 |
63 |
$4K |
| 87430 |
|
195 |
186 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
15 |
14 |
$859.64 |
| 99051 |
|
55 |
54 |
$623.60 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
15 |
14 |
$510.63 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
143 |
124 |
$223.20 |
| A4215 |
Needle, sterile, any size, each |
83 |
76 |
$0.00 |
| A4208 |
Syringe with needle, sterile 3 cc, each |
82 |
75 |
$0.00 |